Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

It’s Holding Steady for Now, But Stay Away From Beyond Meat Stock

By InvestorPlace Research Staff
BYND stock isn't worth the risk as a long-term investment on plant-based meat because Beyond Meat is still at risk of being just a fad.

When it comes to SOS Limited, Investors Are Playing With Fire

By Tom Taulli, InvestorPlace Contributor
In regards to SOS stock, the red flags are starting to pile up. SOS Investors are playing with fire, and must take care not to get burned.

The Genius Brands Story Simply Is Not Worth Buying

By InvestorPlace Research Staff
Genius Brands continues to pitch itself as a big player in streaming. All the company really has accomplished is selling more and more GNUS stock.

AMC Stock and Its Investment Case are Clear: Abandon Ship

By Alex Sirois, InvestorPlace Contributor
AMC stock was already on the wrong path in a slowing industry pre-pandemic. Now it's really desperate and a definite sell.

3 OTC Stocks That Will Eventually Fade Away

By Larry Ramer, InvestorPlace Contributor
These OTC stocks are in weak, vulnerable, highly competitive sectors and generate little revenue at this time.

This Is Not an Obvious Entry Point into Exxon Stock

By Nicolas Chahine, InvestorPlace Contributor
The time to be bullish on XOM stock has passed. Coming into the pandemic crash levels, the opportunity becomes less attractive than last year.

Naked Brands Avoids Going Under, But NAKD Stock Remains Unattractive

By Ian Bezek, InvestorPlace Contributor
Naked Brands has secured a ton of cash. But it's still looking for a successful business model, making NAKD stock unattractive.

SOS Stock Is Both Way Overvalued and Too High-Risk to Take a Chance

By Faizan Farooque, InvestorPlace Contributor
SOS has a solid core business model making it an enticing prospect. But heavy dilution and steep valuation make SOS stock risky right now.

Wake Up And Smell the Coffee With Luckin

By Muslim Farooque, InvestorPlace Contributor
The LKNCY stock comeback story isn't believable considering the uncertainties surrounding the company's bankruptcy and its financial position.

Don’t Fight the Tape With Castor Maritime Stock

By Josh Enomoto, InvestorPlace Contributor
CTRM stock was once an interesting gamble but its seeming dependence on social media makes it an incredibly risky venture.

Heavy Dilution From Cashless Warrants Is Forcing Naked Stock Down

By Mark R. Hake, CFA
Heavy dilution from cashless warrants is forcing NAKD stock down. NAKD stock will likely fall to 48 cents per share as hedge funds arbitrage the dilution.

Bionano Genomics Stock Has Huge Potential, But It’s Very Risky

By Vince Martin, InvestorPlace Contributor
BNGO stock is a play on a potentially disruptive technology. But investors can't forget that most potentially disruptive technologies fail.

You Don’t Want to Be the Last to Know What Zomedica Stock Is Really Worth

By Vince Martin, InvestorPlace Contributor
The retirement of preferred stock seems like a clear win for Zomedica and ZOM stock. But the deal raises a key question as well.

It’s Time to Sell Overvalued QuantumScape Stock

By Larry Ramer, InvestorPlace Contributor
QuantumScape has had a number of positive developments, but the company still faces huge hurdles and QS stock is overvalued.

Ideanomics Is Not Worth the Sum of Its Parts

By Mark R. Hake, CFA
Ideanomics now has a combination of EV-related and non-EV-related segments. Unfortunately, IDEX stock is not worth the sum of these parts.

Be a Smart Horse, Not a Workhorse

By Josh Enomoto, InvestorPlace Contributor
Although WKHS stock wins the popularity argument, the reality is that its core competitor has the overall superior solution.

Catalysts Aside, Tilray Stock Remains a Cannabis Name to Avoid

By InvestorPlace Research Staff
Even with the global legalization trend, and its upcoming merger, you should consider other cannabis plays over TLRY stock.

Is AMC a $5 or a $15 Stock at This Point in the Proceedings?

By Will Ashworth, InvestorPlace Contributor
AMC stock has spent most of 2021 gyrating between $5 and $15. It's at a fork in the road. I’d pass at anything over $7.50.

GameStop Serves Food for the Bears

By Stavros Georgiadis, CFA, InvestorPlace Contributor
GME stock is trying to become more than a meme stock, but wishful thinking does not justifying its lofty valuation.
Load More Articles